The current QBIO market cap is 43.53k. The company's latest EPS is USD -0.0241 and P/E is 0.00.
Year End November 29 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 30k | 196k | 284k |
Operating Income | -9.02M | -8.02M | -13.15M | -7.39M | -3.45M |
Net Income | -9.27M | -10.28M | -14.35M | -8.74M | -3.49M |
Year End November 29 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 3.2M | 640k | 623k | 809k | 3.52M |
Total Liabilities | 3.3M | 5.69M | 1.7M | 5.49M | 8.13M |
Total Equity | -106k | -5.05M | -1.08M | -4.69M | -4.62M |
Year End November 29 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -6.45M | -4.11M | -6.23M | -4.3M | 1.94M |
Investing | -500k | N/A | N/A | N/A | -3.14M |
Financing | 8.81M | 1.59M | 6.24M | 4.47M | 908k |
Market Cap | 43.53k |
Price to Earnings Ratio | 0.00 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 145.09M |
Average Volume (1 week) | 1.13k |
Average Volume (1 Month) | 9.18k |
52 Week Change | -97.74% |
52 Week High | 0.0179 |
52 Week Low | 0.000001 |
Spread (Intraday) | 0 (0%) |
Company Name | Q BioMed Inc (CE) |
Address |
701 s. carson street carson city, nevada 89701 |
Website | https://www.qbiomed.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.